Literature DB >> 14673578

Olfactory dysfunction in cerebellar ataxia and multiple system atrophy.

Michael Abele1, Alexander Riet, Thomas Hummel, Thomas Klockgether, Ullrich Wüllner.   

Abstract

BACKGROUND: Olfactory dysfunction has been reported in Parkinson's (PD) and Alzheimer's disease (AD).
OBJECTIVE: We studied olfactory function in eight patients with multiple system atrophy of cerebellar type (MSA-C), eleven patients with sporadic cerebellar ataxia of unknown etiology and thirteen controls matched for age and gender. Subjects received tests for n-butanol odor thresholds, odor identification, and odor discrimination.
RESULTS: Olfactory thresholds were abnormally high in 16% of the patients. Odor discrimination and odor identification were impaired in 44 % and 74% of the patients, respectively. There was no significant difference in olfactory function between patients with sporadic ataxia of unknown etiology and MSA-C patients.
CONCLUSIONS: The present data suggest that olfactory dysfunction is common to various neurodegenerative disorders and not specifically restricted to PD or AD. Cerebellar dysfunction affected suprathreshold olfactory function more severely than odor thresholds. Thus cerebellar lesions may affect the processing of odor-related information to a higher degree than the transport of odorants to the receptor through sniffing.

Entities:  

Mesh:

Year:  2003        PMID: 14673578     DOI: 10.1007/s00415-003-0248-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.

Authors:  Kiren Ubhi; Edward Rockenstein; Michael Mante; Chandra Inglis; Anthony Adame; Christina Patrick; Kristen Whitney; Eliezer Masliah
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.

Authors:  Pedro Braga-Neto; Lívia Almeida Dutra; José Luiz Pedroso; André C Felício; Helena Alessi; Ruth F Santos-Galduroz; Paulo Henrique F Bertolucci; Mário Luiz V Castiglioni; Rodrigo Affonseca Bressan; Griselda Esther Jara de Garrido; Orlando Graziani Povoas Barsottini; Andrea Jackowski
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

3.  Involvement of the human ventrolateral thalamus in olfaction.

Authors:  S Zobel; T Hummel; J Ilgner; A Finkelmeyer; U Habel; D Timmann; J B Schulz; M Kronenbuerger
Journal:  J Neurol       Date:  2010-07-17       Impact factor: 4.849

4.  Olfactory dysfunction in fragile X tremor ataxia syndrome.

Authors:  Jorge L Juncos; Joash T Lazarus; Julia Rohr; Emily G Allen; Lisa Shubeck; Debra Hamilton; Gloria Novak; Stephanie L Sherman
Journal:  Mov Disord       Date:  2012-09-24       Impact factor: 10.338

5.  Olfactory impairments in patients with unilateral cerebellar lesions are selective to inputs from the contralesional nostril.

Authors:  Joel D Mainland; Bradley N Johnson; Rehan Khan; Richard B Ivry; Noam Sobel
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

6.  Severity of olfactory deficits is reflected in functional brain networks-An fMRI study.

Authors:  Johanna L Reichert; Elbrich M Postma; Paul A M Smeets; Wilbert M Boek; Kees de Graaf; Veronika Schöpf; Sanne Boesveldt
Journal:  Hum Brain Mapp       Date:  2018-03-30       Impact factor: 5.038

Review 7.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

8.  Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases.

Authors:  Luis Velázquez-Pérez; Juan Fernandez-Ruiz; Rosalinda Díaz; Ruth Pérez González; Nalia Canales Ochoa; Gilberto Sánchez Cruz; Luis Enrique Almaguer Mederos; Edilberto Martínez Góngora; Robyn Hudson; René Drucker-Colin
Journal:  J Neurol       Date:  2006-04-11       Impact factor: 4.849

9.  Functional neuroanatomy of human voluntary cough and sniff production.

Authors:  Kristina Simonyan; Ziad S Saad; Torrey M J Loucks; Christopher J Poletto; Christy L Ludlow
Journal:  Neuroimage       Date:  2007-05-24       Impact factor: 6.556

10.  Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy.

Authors:  David S Goldstein; Courtney Holmes; Oladi Bentho; Takuya Sato; Jeffrey Moak; Yehonatan Sharabi; Richard Imrich; Shielah Conant; Basil A Eldadah
Journal:  Parkinsonism Relat Disord       Date:  2008-03-05       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.